Total Payments
$44,600
2024 Payments
$1,758
Companies
60
Transactions
641
Medicare Patients
21,046
Medicare Billing
$2.3M
Payment Breakdown by Category
Other$29,000 (65.0%)
Food & Beverage$13,038 (29.2%)
Travel$1,135 (2.5%)
Gifts$755.15 (1.7%)
Education$671.71 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $29,000 | 15 | 65.0% |
| Food and Beverage | $13,038 | 601 | 29.2% |
| Travel and Lodging | $1,135 | 6 | 2.5% |
| Gift | $755.15 | 2 | 1.7% |
| Education | $671.71 | 17 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Antares Pharma, Inc. | $31,246 | 70 | $0 (2024) |
| Astellas Pharma US Inc | $2,436 | 115 | $0 (2024) |
| AngioDynamics, Inc. | $2,154 | 15 | $0 (2023) |
| COLOPLAST CORP | $895.81 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $768.42 | 34 | $0 (2024) |
| NxThera, Inc. | $699.60 | 2 | $0 (2017) |
| Boston Scientific Corporation | $683.95 | 28 | $0 (2024) |
| ABBVIE INC. | $600.27 | 51 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $586.44 | 48 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $273.52 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 83 | Janssen Biotech, Inc. ($324.53) |
| 2023 | $27,462 | 121 | Antares Pharma, Inc. ($25,196) |
| 2022 | $8,662 | 98 | Antares Pharma, Inc. ($5,172) |
| 2021 | $1,298 | 61 | Antares Pharma, Inc. ($445.93) |
| 2020 | $974.83 | 55 | Antares Pharma, Inc. ($288.38) |
| 2019 | $1,154 | 61 | Astellas Pharma US Inc ($393.24) |
| 2018 | $1,146 | 82 | Astellas Pharma US Inc ($450.80) |
| 2017 | $2,145 | 80 | NxThera, Inc. ($699.60) |
All Payment Transactions
641 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/14/2024 | COLOPLAST CORP | — | Food and Beverage | In-kind items and services | $77.01 | General |
| 12/11/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 12/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Teleflex LLC | SOLESTA (Device) | Food and Beverage | In-kind items and services | $35.19 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/02/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $21.36 | General |
| 10/02/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/23/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 09/19/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 4,979 | 212,089 | $3.4M | $556,652 |
| 2022 | 41 | 5,212 | 206,387 | $3.1M | $546,172 |
| 2021 | 40 | 5,346 | 206,986 | $3.0M | $591,164 |
| 2020 | 48 | 5,509 | 178,462 | $2.6M | $600,846 |
Total Patients
21,046
Total Services
803,924
Medicare Billing
$2.3M
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 833 | 1,302 | $525,852 | $129,545 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 917 | 1,393 | $397,205 | $94,372 | 23.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 206 | 263 | $197,703 | $52,733 | 26.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 58 | 311 | $1.0M | $42,150 | 4.1% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 68 | 82 | $194,263 | $37,864 | 19.5% |
| 53854 | Destruction of prostate tissue using radiofrequency induced heated water vapor | Office | 2023 | 20 | 20 | $119,500 | $29,116 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 176 | 176 | $91,144 | $22,636 | 24.8% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 24 | 148 | $60,680 | $14,497 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 92 | $51,384 | $13,219 | 25.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 89 | 201 | $50,652 | $12,174 | 24.0% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 12 | 12 | $49,346 | $8,819 | 17.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 100 | 108 | $30,888 | $8,026 | 26.0% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 11 | 2,485 | $30,744 | $8,008 | 26.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 597 | 757 | $50,511 | $6,620 | 13.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 1,300 | $23,400 | $6,454 | 27.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 85 | 543 | $37,340 | $6,012 | 16.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 21 | 22 | $21,781 | $5,768 | 26.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 52 | 66 | $108,474 | $5,463 | 5.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 12 | 14 | $17,154 | $4,645 | 27.1% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 13 | 15 | $18,975 | $4,287 | 22.6% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 86 | 198,160 | $27,427 | $4,251 | 15.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 37 | 38 | $30,248 | $3,633 | 12.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $14,747 | $3,533 | 24.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 908 | 1,583 | $14,247 | $3,452 | 24.2% |
| 52317 | Crushing, fragmenting, and removal of bladder stones, less than 2.5 cm | Facility | 2023 | 14 | 15 | $44,145 | $3,175 | 7.2% |
About Dr. Nadeem Rahman, MD
Dr. Nadeem Rahman, MD is a Urology healthcare provider based in Clovis, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467426478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nadeem Rahman, MD has received a total of $44,600 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 641 transactions from 60 companies. The most common payment nature is "Honoraria" ($29,000).
As a Medicare-enrolled provider, Rahman has provided services to 21,046 Medicare beneficiaries, totaling 803,924 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Clovis, CA
- Active Since 02/15/2006
- Last Updated 12/04/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467426478
Products in Payments
- TLANDO (Drug) $19,534
- XYOSTED (Drug) $11,571
- NANOKNIFE (Device) $2,085
- XTANDI (Drug) $1,031
- GEMTESA (Drug) $773.15
- Rezum (Device) $699.60
- Myrbetriq (Drug) $489.71
- Xtandi (Drug) $469.79
- ERLEADA (Drug) $462.85
- OTREXUP (Drug) $332.29
- PROVENGE (Drug) $315.71
- TITAN (Device) $282.43
- MYRBETRIQ (Drug) $280.82
- XIAFLEX (Biological) $244.14
- Androgel (Drug) $236.54
- LUPRON DEPOT (Drug) $204.58
- UROLIFT (Device) $185.86
- ELIGARD (Drug) $179.71
- BOTOX (Biological) $174.19
- CAMCEVI (Drug) $163.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.